REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)

Otsuka

Status: Enrolling

Conditions: Alzheimer Disease

Treatments: Drug: Brexpiprazole (Rexulti)

Study type: Observational

Funder types: Industry

Identifiers

NCT06875986

331-101-00612

Details and patient eligibility

About

The purpose of this study is to evaluate safety of REXULTI in patients under daily clinical settings. In addition, information on efficacy will be collected.

Enrollment: 200 estimated patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with Alzheimer's disease

Exclusion criteria